Clinical Trial Update: Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea [NA]

View source ↗

Summary

This completed clinical trial evaluates whether serum biomarkers can predict the development of type 2 diabetes in patients with obstructive sleep apnea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mike O'Callaghan Military Hospital | Conditions: Obstructive Sleep Apnea, Diabetes Mellitus | NA | Status: COMPLETED